Concepedia

Alastair Mak

AM

Statistics

Publications

8

Citations

279

H-Index

8

Active since

2014

Affiliations

University of Toronto(Current)

Alastair Mak is an author at University of Toronto specializing in immunology, immunopathology, and pharmacology.

Publications per year

2014–2020

8

Publications

8

The Combination of Anti-CTLA-4 and PD1–/– Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury

Alastair Mak, Jack Uetrecht · Chemical Research in Toxicology · 2015 · 76 citations · Full text

, , +16

The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1–/– Mice Cotreated with Anti-CTLA-4

Alastair Mak, Jack Uetrecht · Chemical Research in Toxicology · 2015 · 58 citations · Full text

, , +17

Editor’s Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI

Alastair Mak, Ryuji Kato, Kyle Weston et al. · Toxicological Sciences · 2017 · 43 citations · Full text

, , +16

Immune mechanisms of idiosyncratic drug-induced liver injury

Alastair Mak, Jack Uetrecht · Journal of Clinical and Translational Research · 2017 · 34 citations · Full text

, , +17

Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury

Alastair Mak, Jack Uetrecht · Journal of Immunotoxicology · 2019 · 20 citations · Full text

, , +17

1–5 of 8